NCT06052202Completed
A Smartphone-Based Intervention to Improve Colorectal Cancer Screening in African American Men
Reducing Colorectal Cancer Health Disparities: An mHealth Intervention to Improve Screening Among African American Men
Source: ClinicalTrials.gov · Last updated 2 Jan 2026
Brief summary (registry, in English)
The goal of this clinical trial is to test a new smartphone-based program designed to help African American men get screened for colorectal cancer (CRC). The main question it aims to answer is: ° Are African American men who complete the smartphone-based program more likely to get screened for colorectal cancer than men who do not? Participants will: * Complete a baseline survey asking about their colorectal cancer screening history and their thoughts and beliefs about colorectal cancer and the medical system. * Be randomized to receive the new smartphone-based program or to receive text messages containing colorectal cancer education materials designed by the Centers for Disease Control (CDC). The new program sends text messages with information about colorectal cancer. Some of these text messages have links to videos that try to help men overcome anything that may stand in the way of getting screened. * Complete a follow-up survey 6 months after the baseline survey. This survey will ask the same questions as the baseline survey. * A medical records review will be conducted at 6 months to verify whether participants received a colorectal cancer screening test during the study period. Researchers will compare participants who receive the new smartphone-based program to participants who receive the CDC information. The goal is to see whether the smartphone-based program increasing screening more than standard educational materials available on the internet.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 128 (actual)
- First submitted
- 18 Sept 2023
- Start date
- 8 Dec 2023
- Primary completion date
- 1 May 2025
- Lead sponsor
- ISA Associates, Inc.
- Diseases
- Colorectal cancer
- NCT number
- NCT06052202
What you commit to
- Study type: Interventional
- Participants enrolled: 128
- From 8 Dec 2023 to the primary completion date, 1 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- personal history of colorectal cancer
Who the study is looking for
- African American/Black
- not compliant with current United States Preventive Services Taskforce colorectal cancer screening recommendations
- owns a mobile phone capable of text messaging and accessing webpages
- able to speak/understand English
Age in the registry: 45 years to 75 years · Sex: Male · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| ISA Associates, Inc. Coordinator of this site? Confirm its status | Alexandria | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.